SlateStone Wealth’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
SlateStone Wealth's DXCM Position: Q3 2025 in Review
SlateStone Wealth sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,734 shares — an estimated $239K sold.
SlateStone Wealth first reported a position in DXCM in Q1 2024 and held it in 4 quarters. The position peaked at $260K in Q2 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.
- SlateStone Wealth reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
- SlateStone Wealth sold 2,734 DexCom shares in Q3 2025, an estimated $239K.
- SlateStone Wealth first reported a position in DexCom in Q1 2024 and held it in 4 quarters.
- SlateStone Wealth's DexCom position peaked at $260K in Q2 2024.
- 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.
Based on SlateStone Wealth's 13F filing for Q3 2025, filed 5 Nov 2025.